IMO the us shareholders, esp the ones in it for the long term, do not have to worry about the short term/week-week/day-day share price pattern. The only things that will solidify the share prices are positive news. There are several pieces of news that are due in the coming weeks (up until 30th sept). However only FDA status for ryoncil for sr aGVHD is confirmed for on or before 30th Sept. CHF, CLBP, ARDS is soon (no specific time line-only assumptions).
If those 4 pieces of news are positive then iMO the SP will be in an exponential increase.
If 1 of those is negative and 3 positive then we should still see a general increase in SP.
If from the 4 only 1 piece of news is positive then who knows how the SP goes.
The market if fickle before any confirmed news, thus the SP will fluctuate. We need news to set the SP. Positive news is like 'signing a contract' for the SP and then there is no turning back on it (as an analogy IMO)
HOLD tight. everyone in the same boat. It is that feeling of the positive news being so close, yet so far.
GLTAH
- Forums
- ASX - By Stock
- MSB
- MSB Trading 2020 - a new dawn
MSB Trading 2020 - a new dawn, page-1152
-
- There are more pages in this discussion • 11,919 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8683 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 32999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8683 | 1.155 |
7 | 295447 | 1.150 |
3 | 70786 | 1.145 |
6 | 196386 | 1.140 |
3 | 75486 | 1.135 |
Price($) | Vol. | No. |
---|---|---|
1.165 | 32999 | 1 |
1.170 | 62618 | 6 |
1.175 | 48590 | 3 |
1.180 | 79079 | 4 |
1.185 | 17090 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online